FOX CHASE CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1904-01-01

Employees: -

Market Cap: -

Website: http://www.foxchase.org

Clinical Trials

Computed Tomography in Detecting Movement of the Esophagus in Patients Undergoing Radiation Therapy to the Chest

Not Applicable

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2007-02-12

Last Posted Date: 2010-02-12

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 30

Registration Number: NCT00433524

Locations: 🇺🇸
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer

Phase 2

Terminated

Conditions: Head and Neck Cancer

Interventions: Drug: pemetrexed
Drug: gemcitabine

First Posted Date: 2006-10-31

Last Posted Date: 2022-08-05

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 17

Registration Number: NCT00394147

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

Not Applicable

Completed

Conditions: Breast Cancer
Colorectal Cancer
Psychosocial Effects of Cancer and Its Treatment
Thymoma and Thymic Carcinoma
Malignant Mesothelioma
Prostate Cancer
Lung Cancer

Interventions: Other: educational intervention
Procedure: psychosocial assessment and care
Procedure: quality-of-life assessment

First Posted Date: 2006-09-07

Last Posted Date: 2020-03-02

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 340

Registration Number: NCT00372840

Locations: 🇺🇸
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking

Phase 4

Completed

Conditions: Bladder Cancer
Gastric Cancer
Cervical Cancer
Esophageal Cancer
Kidney Cancer
Head and Neck Cancer
Leukemia
Pancreatic Cancer
Liver Cancer
Lung Cancer

Interventions: Drug: nicotine patch
Drug: nicotine lozenge

First Posted Date: 2006-08-17

Last Posted Date: 2016-03-29

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 642

Registration Number: NCT00365508

Locations: 🇺🇸
Medical College of Georgia Cancer Center, Augusta, Georgia, United States
🇺🇸
Hematology Oncology Associates of Central New York, PC - Northeast Center, East Syracuse, New York, United States
🇺🇸
Geisinger Cancer Institute at Geisinger Health, Danville, Pennsylvania, United States

and more 7 locations

Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer

Phase 3

Completed

Conditions: Colorectal Cancer

First Posted Date: 2006-07-14

Last Posted Date: 2014-05-16

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 660

Registration Number: NCT00352638

Locations: 🇺🇸
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States
🇺🇸
Helen F. Graham Cancer Center at Christiana Care, Newark, Delaware, United States
🇺🇸
Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton, Marlton, New Jersey, United States

and more 15 locations

Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer

Phase 2

Completed

Conditions: Urologic Neoplasm

Interventions: Drug: Cetuximab
Drug: Paclitaxel

First Posted Date: 2006-07-10

Last Posted Date: 2017-03-31

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 41

Registration Number: NCT00350025

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis

Phase 2

Terminated

Conditions: Parapsoriasis

First Posted Date: 2006-05-05

Last Posted Date: 2013-04-16

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 8

Registration Number: NCT00322296

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab

Phase 2

Terminated

Conditions: Colorectal Neoplasms

Interventions: Drug: bevacizumab
Drug: cetuximab
Drug: Oxaliplatin
Drug: Capecitabine

First Posted Date: 2006-05-03

Last Posted Date: 2022-01-12

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 23

Registration Number: NCT00321100

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer

Phase 2

Completed

Conditions: Carcinoma, Non-Small-Cell Lung

First Posted Date: 2006-04-18

Last Posted Date: 2010-09-23

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 53

Registration Number: NCT00315185

Locations: 🇺🇸
Consultants in Medical Oncology & Hematology Inc., Drexel Hill, Pennsylvania, United States

Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer

Phase 3

Completed

Conditions: Metastatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2005-10-27

Last Posted Date: 2013-01-29

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 720

Registration Number: NCT00244868

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸
MBCCOP - Meharry Medical College - Nashville, Nashville, Tennessee, United States
🇺🇸
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy